Sort
40,608 grants matching “prostate cancer”
Mechanisms of TGFbeta Production in Human Cancer Cells
$319,343Pennsylvania State Univ Hershey Med Ctr · R01 · FY2005 · CA
Mechanisms of TGFbeta Production in Human Cancer Cells
$319,343Pennsylvania State Univ Hershey Med Ctr · R01 · FY2004 · CA
Mechanisms of TGFbeta Production in Human Cancer Cells
$319,343Pennsylvania State Univ Hershey Med Ctr · R01 · FY2003 · CA
Anticarcinogenic Effect of ITCs Against Prostate Cancer
$319,332Shivendra Singh · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA
Anticarcinogenic Effect of ITCs Against Prostate Cancer
$319,332Shivendra Singh · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · CA
CYCLIN B1 IN IMMUNOTHERAPY, DIAGNOSIS, AND PROGNOSIS OF LUNG CANCER
$319,325Olivera J Finn · University Of Pittsburgh At Pittsburgh · P50 · FY2008 · CA
Mechanism of promiscuous AR activation in PTEN-mutated prostate cancer
$319,323Haojie Huang · Mayo Clinic Rochester · R01 · FY2012 · CA
Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents
$319,291Ching-Shih Chen · Ohio State University · R01 · FY2014 · CA
Local Radiation as an Adjuvant for Immunotherapy
$319,279Sandra Demaria · New York University School Of Medicine · R01 · FY2007 · CA
Hypoxia and Radiotherapy: Evaluation and Mitigation in Tumors
$319,272Ralph P Mason · Ut Southwestern Medical Center · R01 · FY2012 · CA
Microsatellite Sequencing to Enable Cancer Genotyping
$319,268Anna Schibel · Electronic Biosciences, Inc. · R21 · FY2019 · CA
Highly Paramagnetic, Biodegradable Nanoclusters for Imaging Prostate Cancer
$319,263Andrew Tsourkas · University Of Pennsylvania · R01 · FY2014 · CA
Small Molecule PSMA-Targeted Alpha Therapy
$319,250Martin G Pomper · Johns Hopkins University · R01 · FY2020 · CA
Specific Recognition of G-quadruplexes
$319,224Hanbin Mao · Kent State University · R01 · FY2021 · CA
MicroRNAs in differentiation of muscle
$319,211Anindya Dutta · University Of Virginia · R01 · FY2008 · AR
MicroRNAs in differentiation of muscle
$319,211Anindya Dutta · University Of Virginia · R01 · FY2009 · AR
Transcriptional Repression by Polycomb Group Products
$319,203Jeffrey A Simon · University Of Minnesota · R01 · FY2010 · GM
Project 1: Acid Ceramidase-S1P Metabolic Axis and Regulation of Tumor Resistance to Apoptosis
$319,172Christina Voelkel-Johnson · Medical University Of South Carolina · P01 · FY2021 · CA
The role of Klf5 in GI epithelial homeostasis and disease
$319,167Jonathan P Katz · University Of Pennsylvania · R01 · FY2009 · DK
Active surveillance and patient reported outcomes in a diverse population of prostate cancer patients
$319,123Scarlett L Gomez · University Of California, San Francisco · R01 · FY2022 · CA
Molecular Targeted Radionuclide Therapy with Tumor-Specific Vaccine to Stimulate and Expand T-cell Activation
$319,122Douglas G McNeel · University Of Wisconsin-Madison · P01 · FY2022 · CA
Molecular Targeted Radionuclide Therapy with Tumor-Specific Vaccine to Stimulate and Expand T-cell Activation
$319,121Douglas G McNeel · University Of Wisconsin-Madison · P01 · FY2023 · CA
Pragmatic Trial
$319,087Michael J Morris · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
PREVENTION OF PROSTATE CARCINOGENESIS BY NEXT-GENERATION SELENIUM
$319,073Junxuan Lu · Texas Tech University Health Scis Center · R01 · FY2015 · CA
A multidisciplinary training program in prostate cancer
$319,057Neil A Bhowmick · Cedars-Sinai Medical Center · T32 · FY2023 · CA